VKS-21557-60027
3 vaccinations
3 coded responses
37 check-ins
3 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 980 / WA
- Registered
- 2021-03-01
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-01
Registered in v-safe
-
2021-03-02
Dose 1 — Pfizer-BioNTech
-
2021-03-02
Health check-in — day 0, dose 1Feeling: Good · Site: Pain · Fatigue or tiredness, Abdominal painAdult check-in
- 2021-03-03
- 2021-03-04
- 2021-03-05
- 2021-03-06
- 2021-03-07
- 2021-03-08
- 2021-03-09
- 2021-03-16
-
2021-03-23
Dose 2 — Pfizer-BioNTech
- 2021-03-23
-
2021-03-24
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-03-25
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
- 2021-03-26
- 2021-03-28
- 2021-03-29
- 2021-03-30
- 2021-04-06
- 2021-04-13
- 2021-04-21
-
2021-04-27
Survey response — day 35, dose 2MedDRA: Fatigue — Feeling: FairFree text: FatigueMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-05
- 2021-06-22
- 2021-09-21
-
2022-01-14
Dose 3 — Pfizer-BioNTech
-
2022-01-15
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Muscle or body aches · Be unable to do your normal daily activitiesAdult check-in
-
2022-01-16
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
-
2022-01-17
Survey response — days 1–6 daily, dose 3MedDRA: Rhinorrhoea — Feeling: GoodFree text: Runny noseMedDRA releases: 2024-11 · check-in free text available
-
2022-01-18
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Fever · Muscle or body aches · Be unable to do your normal daily activitiesAdult check-in
- 2022-01-19
- 2022-01-20
- 2022-01-21
-
2022-01-28
Survey response — day 14, dose 3MedDRA: Nasopharyngitis — Feeling: Good · Be unable to do your normal daily activitiesFree text: Cold like symptoms. Possibly Covid but all testing sites were full so I was not able to get tested.MedDRA releases: 2024-11 · check-in free text available
- 2022-02-04
- 2022-02-11
- 2022-02-18
- 2022-02-25
- 2022-04-15
- 2022-07-17
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-02 | Pfizer-BioNTech | |
| 2 | 2021-03-23 | Pfizer-BioNTech | |
| 3 | 2022-01-14 | Pfizer-BioNTech | No |
Free text
Release 8 — day 35, dose 2
Symptoms: Fatigue
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Runny nose
Release 11 — day 14, dose 3
Symptoms: Cold like symptoms. Possibly Covid but all testing sites were full so I was not able to get tested.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SRO | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release